PAPER Kokhan VS, Nesterov MS, Levashova AI
SEARCH RESULTS
331159 RESULTS
PAPER Wang ZG, Sharma A, Feng L, Muresanu DF, Tian ZR, Lafuente JV, Buzoianu AD, Nozari A, Huang H, Chen L, Manzhulo I, Wiklund L, Sharma HS
Co-administration of dl-3-n-butylphthalide and neprilysin is neuroprotective in Alzheimer disease associated with mild traumatic brain injury.
Int Rev Neurobiol. 2023;172:145-185. Epub 2023 Sep 26 PubMed: 37833011PAPER Braun M, Boström G, Ingelsson M, Kilander L, Löwenmark M, Nyholm D, Burman J, Niemelä V, Freyhult E, Kultima K, Virhammar J
Levels of inflammatory cytokines MCP-1, CCL4, and PD-L1 in CSF differentiate idiopathic normal pressure hydrocephalus from neurodegenerative diseases.
Fluids Barriers CNS. 2023 Oct 13;20(1):72. PubMed: 37833765PAPER Khemka S, Reddy A, Garcia RI, Jacobs M, Reddy RP, Roghani AK, Pattoor V, Basu T, Sehar U, Reddy PH
Role of diet and exercise in aging, Alzheimer's disease, and other chronic diseases.
Ageing Res Rev. 2023 Nov;91:102091. Epub 2023 Oct 11 PubMed: 37832608PAPER Hepp DH, van Wageningen TA, Kuiper KL, van Dijk KD, Oosterveld LP, Berendse HW, van de Berg WD
Inflammatory Blood Biomarkers Are Associated with Long-Term Clinical Disease Severity in Parkinson's Disease.
Int J Mol Sci. 2023 Oct 5;24(19) PubMed: 37834363PAPER Won SY, Kim YC, Jeong BH
Elevated E200K Somatic Mutation of the Prion Protein Gene (PRNP) in the Brain Tissues of Patients with Sporadic Creutzfeldt-Jakob Disease (CJD).
Int J Mol Sci. 2023 Oct 2;24(19) PubMed: 37834279PAPER Orobets KS, Karamyshev AL
Amyloid Precursor Protein and Alzheimer's Disease.
Int J Mol Sci. 2023 Sep 30;24(19) PubMed: 37834241PAPER Zaręba P, Łątka K, Mazur G, Gryzło B, Pasieka A, Godyń J, Panek D, Skrzypczak-Wiercioch A, Höfner GC, Latacz G, Maj M, Espargaró A, Sabaté R, Jóźwiak K, Wanner KT, Sałat K, Malawska B, Kulig K, Bajda M
Discovery of novel multifunctional ligands targeting GABA transporters, butyrylcholinesterase, β-secretase, and amyloid β aggregation as potential treatment of Alzheimer's disease.
Eur J Med Chem. 2023 Dec 5;261:115832. Epub 2023 Oct 7 PubMed: 37837674PAPER Kumar R, Malik MZ, Thanaraj TA, Bagabir SA, Haque S, Tambuwala M, Haider S
A computational biology approach to identify potential protein biomarkers and drug targets for sporadic amyotrophic lateral sclerosis.
Cell Signal. 2023 Dec;112:110915. Epub 2023 Oct 13 PubMed: 37838312PAPER Cao R, Chen C, Wen J, Zhao W, Zhang C, Sun L, Yuan L, Wu C, Shan L, Xi M, Sun H
Recent advances in targeting leucine-rich repeat kinase 2 as a potential strategy for the treatment of Parkinson's disease.
Bioorg Chem. 2023 Dec;141:106906. Epub 2023 Oct 7 PubMed: 37837728PAPER Horvath JD, Casas M, Kutchukian C, Sánchez SC, Pergande MR, Cologna SM, Simó S, Dixon RE, Dickson EJ
α-Synuclein-dependent increases in PIP5K1γ drive inositol signaling to promote neurotoxicity.
Cell Rep. 2023 Oct 31;42(10):113244. Epub 2023 Oct 14 PubMed: 37838947PAPER Catterson JH, Minkley L, Aspe S, Judd-Mole S, Moura S, Dyson MC, Rajasingam A, Woodling NS, Atilano ML, Ahmad M, Durrant CS, Spires-Jones TL, Partridge L
Protein retention in the endoplasmic reticulum rescues Aβ toxicity in Drosophila.
Neurobiol Aging. 2023 Dec;132:154-174. Epub 2023 Sep 21 PubMed: 37837732PAPER Lee J, Weerasinghe-Mudiyanselage PD, Kim B, Kang S, Kim JS, Moon C
Particulate matter exposure and neurodegenerative diseases: A comprehensive update on toxicity and mechanisms.
Ecotoxicol Environ Saf. 2023 Nov 1;266:115565. Epub 2023 Oct 11 PubMed: 37832485PAPER Li HY, Liu DS, Zhang YB, Rong H, Zhang XJ
The interaction between alpha-synuclein and mitochondrial dysfunction in Parkinson's disease.
Biophys Chem. 2023 Dec;303:107122. Epub 2023 Oct 10 PubMed: 37839353PAPER Zhang Z, Xie X, Cai Y, Liu P, Liu S, Chen R, Wang J, Wang Y, Zhao Y, Zhu Z, Zhang X, Wu J
Abnormal immune function of B lymphocyte in peripheral blood of Parkinson's disease.
Parkinsonism Relat Disord. 2023 Nov;116:105890. Epub 2023 Oct 11 PubMed: 37839276Current Filters
No filters selected